期刊文献+

586例肿瘤患者贫血发生率调查 被引量:10

Clinical analysis of anemia in patients with tumor
暂未订购
导出
摘要 目的分析各系统肿瘤患者中贫血的发生率和程度。方法对2002年6月~2006年12月在我院肿瘤血液科住院的586例肿瘤患者的临床资料进行回顾性分析。结果肿瘤患者贫血的发生率达45.73%,其中Ⅰ、Ⅱ度为68.28%,Ⅲ、Ⅳ为度31.72%。血液系统肿瘤贫血的发生率最高为58.67%,泌尿生殖系统为50.00%,消化道肿瘤为46.91%,乳腺癌为41.94%,肺癌为24.59%,其他肿瘤为44.78%。肿瘤患者有贫血症状的为66.42%,采取治疗措施的13.06%,出院有贫血诊断的仅为1.12%。结论肿瘤患者贫血发生率高,漏诊率高,治疗率低,应引起医师的高度重视。 Objectives To analyse the incidence of anemia in patients hospitalized with the primary diagnosis of malignant tumors. Methods In 586 patients who were admitted to the medical wards with a primary diagnosis of tumor, the hemoglobin (Hb) , age, sex, and type of tumor were recorded. Anemia was considered to be present when the Hb on admission was 〈 11 g/dl. Results A total of 268 (45.73%) of the 586 patients had a Hb 〈 11 g/dl on admission. Among these patients, Ⅰ -Ⅱ grade anemia accouted for 68. 28% , Ⅲ - Ⅳ grade 31.72%. One hundred four (46. 85% ) of the 222 females were anemic compared to 164 (45.06%) of the 364 male. The incidence of hemologic malignancies was 58.67% , urinogenital cancers 50. 00%, digestive system cancers 46. 91%, breast cancers 41.94%, and lung cancers 24. 59%. Only 3 ( 1.12% ) patients had anemia on discharge. Conclusion The incidence of anemia is high in patients hospitalized with tumor, but only few has been diagnosed and treated.
机构地区 解放军第
出处 《癌症进展》 2007年第6期582-584,566,共4页 Oncology Progress
关键词 贫血 肿瘤 anemia tumor
  • 相关文献

参考文献7

二级参考文献43

  • 1[1]Moliterno AR,Spivak JL. Anemia of cancer[J].Hematol Oncol Clin North Am,1996,10(2):345-363.
  • 2[2]Ludwig H. Epoetin in cancer-related anemia[J].Nephrol Dial Transplant,1999,14(Suppl 2):85-92.
  • 3[3]Cella D. Factors influencing quality of life in cancer patients anemia and fatigue[J].Semin Oncol,1998,25 (3 Suppl7):43-46.
  • 4[4]Ware JE,Sherbourne CD. The MOS 36-item short-form health survey (SF-36):I.Conceptual framework and item selection[J].Med Care,1992,30(6):473-483.
  • 5[5]Steven Soignet. Management of Cancer Related Anemia:Epoetin Alfa and quality of life[J].Semin Oncol,2000,37(Suppl 6):9-13.
  • 6[6]Demetri GD,Kris M,Wade J,et al. Quality of life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type.Results from a prospective community oncology study[J].J Clin Oncol,1998,16(10):3412-3425.
  • 7Denko NC, Giaccia AJ. Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy )and metastasis[J]. Cancer Res, 2001,61 (3) :795 -798.
  • 8Momerency G, van Cauwenberghe K, Higldey M, et aL Partitioning of ifosfamide and its metabelites between red blood cells and plasma[J]. J Pharm Sci, 1996,85(2) :262 -265.
  • 9Groopman JE, Itri LM. Chemotherapy-induced anemia in adults:incidence and treatment[J]. J Nail Cancer Inst, 1999,91 (19) :1616 - 1634.
  • 10Caro JJ, Salas M, Ward A, et aJ. Anemia as an independent prognostic factor for survival in patients with cancer: a systematic,quantitative review[ J]. Cancer, 2001,91 (12) :2214 -2221.

共引文献90

同被引文献100

引证文献10

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部